IP Library Granted Patent US 8,618,352
Granted Patent B2
US 8,618,352 · App. 12/283,980 · Granted Dec 31, 2013

Transgenic porcine models of cystic fibrosis

Inventors: Michael J. Welsh (Riverside, IA); Christopher S. Rogers (North Liberty, IA); Randall Prather (Rocheport, MO); John Engelhardt (Iowa City, IA); Ziying Yan (Iowa City, IA)
Assignees: University of Iowa Research Foundation; The Curators of the University of Missouri
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,618,352
App. No.
12/283,980
Granted
Dec 31, 2013
Kind
B2
Abstract

The present invention provides transgenic, large non-human animal models of diseases and conditions, as well as methods of making and using such animal models in the identification and characterization of therapies for the diseases and conditions.

Claims (15)

1. A transgenic pig whose genome comprises a homozygous disruption of a cystic fibrosis membrane transporter (CFTR) gene, wherein the pig does not express functional CFTR, and wherein the pig has a symptom of cystic fibrosis in its pancreas, intestine, liver, or gallbladder.

2. The transgenic pig of claim 1 , wherein the disruption comprises an insertion of an exogenous nucleic acid molecule and/or a transcription termination sequence.

3. A cell isolated from the transgenic pig of claim 1 .

4. A method of making the transgenic pig of claim 1 comprising:

i) disrupting a CFTR gene in a fetal pig fibroblast;

ii) introducing the nucleus of the fetal pig fibroblast into an enucleated pig oocyte to generate a pig embryo;

iii) transferring the pig embryo into a recipient female such that a transgenic pig whose genome comprises a heterozygous disruption of the CFTR gene is obtained; and

iv) breeding the pig obtained in iii) such that the transgenic pig of claim 1 is obtained.

5. The transgenic pig of claim 1 , wherein the pig has a symptom of cystic fibrosis in its pancreas.

6. The transgenic pig of claim 5 , wherein the pig has a symptom of cystic fibrosis in its pancreas comprising exocrine pancreatic insufficiency.

7. The transgenic pig of claim 1 , wherein the pig has a symptom of cystic fibrosis in its intestine.

8. The transgenic pig of claim 7 , wherein the pig has a symptom of cystic fibrosis in its intestine comprising meconium ileus or intestinal obstruction.

9. The transgenic pig of claim 1 , wherein the pig has a symptom of cystic fibrosis in its liver.

10. The transgenic pig of claim 9 , wherein the pig has a symptom of cystic fibrosis in its liver comprising focal biliary cirrhosis.

11. The transgenic pig of claim 1 , wherein the pig has a symptom of cystic fibrosis in its gallbladder.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jan 16, 2014
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032040/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2010
From: WELSH, MICHAEL J.; ROGERS, CHRISTOPHER S.; ENGELHARDT, JOHN; YAN, ZIYING
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 024040/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2010
From: PRATHER, RANDALL S.
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 024040/0860 →
CONFIRMATORY LICENSE Recorded Jun 3, 2009
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022772/0634 →
Continuity (4)
Continuation In Part 12074632 · Mar 5, 2008
Provisional Application 60966971 · Aug 30, 2007
Provisional Application 60908637 · Mar 28, 2007
Related Publication 20090241203A1 · Sep 24, 2009